ATAI Life Sciences Terminates Hercules Loan Agreement with Prepayment of $21.8 Million

Strategic Insights -

ATAI Life Sciences N.V. has voluntarily pre-paid its outstanding loan obligation under the Hercules Loan Agreement with Hercules Capital, Inc., paying off approximately $21.8 million on May 2, 2025. This decision allowed the company to avoid loan amortization payments and interest due under the full amortization payment schedule, resulting in a savings of approximately $2.1 million. Despite the early prepayment, the company incurred a prepayment fee equal to 0.50% of the outstanding principal balance, totaling $0.1 million. The Hercules Loan Agreement was secured by a lien on substantially all of the company's assets, with certain limited exceptions, and has been terminated with the release of liens and security interests.

Key Takeaways:

  • ATAI Life Sciences N.V. has pre-paid its outstanding loan obligation under the Hercules Loan Agreement with Hercules Capital, Inc. for approximately $21.8 million on May 2, 2025.
  • The prepayment resulted in a savings of approximately $2.1 million compared to the full amortization payment schedule, but also incurred a prepayment fee equal to 0.50% of the outstanding principal balance totaling $0.1 million.
  • The Hercules Loan Agreement was secured by a lien on substantially all of the company's assets, with certain limited exceptions, and has been terminated with the release of liens and security interests.
  • The termination of the Hercules Loan Agreement is expected to provide the company with greater flexibility in managing its debt obligations and capital structure.
  • The company's Chief Executive Officer, Srinivas Rao, signed the report on May 8, 2025, certifying the accuracy of the information contained in the report.

Statistics:

  • The prepayment amount was approximately $21.8 million.
  • The savings from prepayment was calculated to be approximately $2.1 million.
  • The prepayment fee was equal to 0.50% of the outstanding principal balance, totaling $0.1 million.
  • The Hercules Loan Agreement had a maturity date of August 1, 2026, with loan amortization payments beginning on September 1, 2025.
  • The company released and terminated all liens or security interests granted to secure the obligations under the Hercules Loan Agreement.

Sources:

  • UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT
  • ATAI LIFE SCIENCES N.V., FORM 8-K (Current Report), filed with the U.S. Securities and Exchange Commission on May 08, 2025